Aquestive Therapeutics Inc. Common Stock (AQST)
Stock · NASDAQ · Health Care
$5.02as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$4.12
Industry
Biotechnology: Pharmaceutical Preparations
Fundamentals
- Market cap
- $475.52M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
How Aquestive Therapeutics Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 4, 2026 · via SEC EDGAR / Finnhub
Aquestive Therapeutics Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- AQSTAquestive Therapeutics Inc. Common Stock$5.02▼ 2.71%Market cap $475.52MP/E —
- QTTBQ32 Bio Inc. Common Stock$15.01▼ 7.06%Market cap $451.37MP/E 15.71$1.62$23.57
- SGMTSagimet Biosciences Inc. Series A Common Stock$10.55▼ 1.86%Market cap $441.53MP/E —$4.5$11.15
- PRTAProthena Corporation plc Ordinary Shares$9.35▲ 2.86%Market cap $436.10MP/E —$7.73$11.8
- ARVNArvinas Inc. Common Stock$9.16▼ 0.87%Market cap $520.04MP/E 62.96$6.97$14.51
- BNTCBenitec Biopharma Inc. Common Stock$12.51▼ 1.30%Market cap $417.41MP/E —$9.85$16.76
- KMDAKamada Ltd. Ordinary Shares$8.29▲ 0.36%Market cap $417.07MP/E 20.65$6.5$9.35
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AQST Aquestive Therapeutics Inc. Common Stock | $475.52M | — | $5.02 | ▼ 2.71% | |
| QTTB Q32 Bio Inc. Common Stock | $451.37M | 15.71 | $15.01 | ▼ 7.06% | $1.62$23.57 |
| SGMT Sagimet Biosciences Inc. Series A Common Stock | $441.53M | — | $10.55 | ▼ 1.86% | $4.5$11.15 |
| PRTA Prothena Corporation plc Ordinary Shares | $436.10M | — | $9.35 | ▲ 2.86% | $7.73$11.8 |
| ARVN Arvinas Inc. Common Stock | $520.04M | 62.96 | $9.16 | ▼ 0.87% | $6.97$14.51 |
| BNTC Benitec Biopharma Inc. Common Stock | $417.41M | — | $12.51 | ▼ 1.30% | $9.85$16.76 |
| KMDA Kamada Ltd. Ordinary Shares | $417.07M | 20.65 | $8.29 | ▲ 0.36% | $6.5$9.35 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Aquestive Therapeutics: Potential Catalyst On The HorizonSeekingAlpha · 8/19/2026
- Aquestive Therapeutics, Inc. (AQST) Q2 2026 Earnings Call TranscriptSeekingAlpha · 8/12/2026
- Aquestive Therapeutics, Inc. 2026 Q2 - Results - Earnings Call PresentationSeekingAlpha · 8/12/2026
- Aquestive Therapeutics Affirms FY2026 Sales Guidance of $46.000M-$50.000M vs $50.584M EstBenzinga · 8/11/2026
- Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful StudyBenzinga · 8/10/2026
- Varex Imaging Posts Upbeat Q3 Earnings, Joins Bowman Consulting, MarineMax And Other Big Stocks Moving Higher On MondayBenzinga · 8/10/2026
Insider Activity
Insider Actions →Acquired
452.5K
Disposed
136.5K
- Daniel Barber · July 16, 2026 · Sale20.4K @ $4
- Daniel Barber · July 15, 2026 · Sale4.6K @ $4.03
- Julie Krop · June 23, 2026 · Option Exercise25.0K @ $0.7132
- Julie Krop · June 23, 2026 · Sale25.0K @ $5.02
- Daniel Barber · June 15, 2026 · Sale25.0K @ $4.16
- Julie Krop · June 10, 2026 · Grant50.5K
- Jenkins Abigail L. · June 10, 2026 · Grant50.5K
- Cochran John · June 10, 2026 · Grant50.5K
- Taglietti Marco · June 10, 2026 · Grant50.5K
- BROWN GREGORY B · June 10, 2026 · Grant50.5K
- Timothy E. Morris · June 10, 2026 · Grant50.5K
- Sherry Korczynski · June 8, 2026 · Tax Withholding2.7K
- Thomas A. Zalewski · May 18, 2026 · Grant75.0K
- Thomas A. Zalewski · May 18, 2026 · Grant100.0K
- Daniel Barber · May 15, 2026 · Sale8.3K @ $4.29
Institutional Ownership
March 31, 2026
- Total shares held
- 69.07M
- Total value held
- $281.95M
- Institutional holders
- 176
Top holders this quarter
- Unknown9.81M
- Unknown7.51M
- Unknown7.43M
- Unknown2.94M
- Unknown2.90M
- Unknown2.55M
- Unknown2.50M
- Unknown2.41M
- Unknown2.41M
- Unknown1.92M
See the full, filterable feed with live charts on the MarketWall dashboard.